Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical, Inc. (NYSE:GMED) shares are trading higher Wednesday after the company posted better-than-expected first-quarter financial results and raised its fiscal year 2024 guidance.
Globus Medical, Inc.（纽约证券交易所代码：GMED）股价周三上涨，此前该公司公布的第一季度财务业绩好于预期，并上调了2024财年预期。
The Details:
细节：
Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last year.
Globus Medical公布的季度每股收益为72美分，比分析师普遍预期的57美分高出26.32％，比去年同期的收益增长了35.85％。
Quarterly sales came in at $606.67 million which beat the analyst consensus estimate by 3.33% and is a 119.26% increase in sales year-over-year.
季度销售额为6.0667亿美元，比分析师的普遍预期高出3.33％，销售额同比增长119.26％。
"Since the NuVasive merger closed in September of last year, we worked aggressively to execute our integration strategy and are making significant progress towards rapidly reaching steady state. I am pleased with the first quarter results delivered by strong teamwork and partnership throughout our organization. Surgeons and hospitals are responding favorably to our best-in-class product offering of clinically advanced devices and enabling technologies and worldwide sales reflect the long-term potential of our company," said Dan Scavilla, CEO of Globus Medical.
“自去年9月Nuvasive合并完成以来，我们积极努力执行整合战略，并在迅速达到稳定状态方面取得了重大进展。我对整个组织中强大的团队合作和伙伴关系所带来的第一季度业绩感到满意。外科医生和医院对我们提供临床先进设备的一流产品反应良好，支持技术和全球销售反映了我们公司的长期潜力。” Globus Medical首席执行官丹·斯卡维拉说。
Outlook:
展望：
The company updated its guidance for full year 2024 revenue to be in the range of $2.46 billion to $2.485 billion and earnings per share in the range of $2.75 to $2.85. The updated guidance is an increase over the prior full year 2024 revenue guidance of $2.45 billion to $2.475 billion and earnings per share guidance of $2.68 to $2.70.
该公司更新了2024年全年收入的指导方针，使其在24.6亿美元至24.85亿美元之间，每股收益在27.5美元至2.85美元之间。更新的指引比之前的2024年全年收入预期增加了24.5亿美元至24.75亿美元，每股收益预期为268美元至27美元。
Analysts React:
分析师的反应：
Multiple analysts raised their price targets on the stock after the print:
多位分析师在公布后提高了该股的目标股价：
- BTIG analyst Ryan Zimmerman maintained a Buy rating and raised the price target from $60 to $63.
- Piper Sandler maintained Globus Medical with a Neutral and raised its price target from $55 to $60.
- Stifel analyst Mathew Blackman maintained a Buy rating and raised the price target from $64 to $70.
- BTIG分析师瑞安·齐默尔曼维持买入评级，并将目标股价从60美元上调至63美元。
- 派珀·桑德勒将Globus Medical维持在中性水平，并将其目标股价从55美元上调至60美元。
- Stifel分析师马修·布莱克曼维持买入评级，并将目标股价从64美元上调至70美元。
Related News: Reddit Shares Soar On First Post-IPO Q1 Results, Strong Q2 Guidance
相关新闻： Reddit 股价因首次公开募股后的第一季度业绩和强劲的第二季度指引而飙升
GMED Price Action: According to Benzinga Pro, Globus Medical shares are up 23.6% at $63.50 at the time of publication Wednesday.
GMED价格走势：根据Benzinga Pro的数据，截至周三发布时，Globus Medical的股价上涨了23.6％，至63.50美元。
Image: PublicDomainPictures from Pixabay
图片：来自 Pixabay 的 PublicDomainPic